Auto-Antibodies and Their Association with Clinical Findings in Women Diagnosed with Microscopic Colitis

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Roth, Bodil ^a   Gustafsson, Rita J ^a   Ohlsson, Bodil ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; GLUTAMATE DECARBOXYLASE ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; ISLET ANTIGEN LIKE INSULIN 2; NEUTROPHIL CYTOPLASMIC ANTIBODY; SACCHAROMYCES CEREVISIAE ANTIBODY; THYROID PEROXIDASE ANTIBODY; THYROTROPIN RECEPTOR ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ALLERGY; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTENSION; IRRITABLE COLON; MAJOR CLINICAL STUDY; MEDICAL HISTORY; MICROSCOPIC COLITIS; POPULATION RESEARCH; PROTEIN EXPRESSION; PROTEIN FUNCTION; SCORING SYSTEM;

AGED; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODIES, ANTINUCLEAR; ANTIBODIES, FUNGAL; AUTOANTIBODIES; COLITIS, MICROSCOPIC; FEMALE; HUMANS; IODIDE PEROXIDASE; MIDDLE AGED; RECEPTORS, THYROTROPIN; SACCHAROMYCES CEREVISIAE;

SACCHAROMYCES CEREVISIAE;

EID: 84878895996     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066088     Document Type: Article

References (41)

1. Carmack SW, Lash RH, Gulizia JM, Genta RM, (2009) Lymphocytic disorders of the gastrointestinal tract: a review for the practicing pathologist. Adv Anat Pathol 16: 290-306.
2. Koskela RM, Karttunen TJ, Niemelä SE, Lehtola JK, Ilonen J, et al. (2008) Human leucocyte antigen and TNFalpha polymorphism association in microscopic colitis. Eur J Gastroenterol Hepatol 20: 276-282.
3. Bohr J, Tysk C, Yang P, Danielsson D, Järnerot G, (1996) Autoantibodies and immnuoglobulins in collagenous colitis. Gut 39: 73-76.
4. Holstein A, Burmeister J, Plaschke A, Rosemeier D, Widjaja A, et al. (2006) Autoantibody profiles in microscopic colitis. J Gastroenterol Hepatol 21: 1016-1020.
5. Pilia S, Casini MR, Cambuli VM, Ibba A, Civolani P, et al. (2011) Prevalence of Type 1 diabetes autoantibodies (GAD and IA2) in Sardinian children and adolescents with autoimmune thyroiditis. Diabet Med 28: 896-899.
6. Op De Beéck K, Maes L, Van den Bergh K, Derua R, Waelkens E, et al. (2012) Heterogeneous nuclear RNPs as targets of autoantibodies in systemic rheumatic diseases. Arthritis Rheum 64: 213-221.
7. Duerr RH, Targan SR, Landers CJ, Sutherland LR, Shanahan F, (1991) Anti-neutrophil cytoplasmic antibodies in ulcerative colitis. Comparison with other colitides/diarrheal illnesses. Gastroenterology 100: 1590-1596.
8. Prideaux L, de Cruz P, Ng SC, Kamm MA, (2012) Serological antibodies in inflammatory bowel disease: a systematic review. Inflamm Bowel Dis 18: 1340-1355.
9. Pardi DS, Kelly CP, (2011) Microscopic Colitis. Gastroenterology 140: 1155-1165.
10. Gal AA, Velasquez A, (2002) Antineutrophil cytoplasmic autoantibody in the absence of Wegeneŕs granulomatosis or microscopic polyangitis: implications for the surgical pathologist. Mod Pathol 15: 197-204.
11. Bonifacio E, Bingley PJ, (1997) Islet autoanibodies and their use in predicting insulin-dependent diabetes. Acta Diabetol 34: 185-193.
12. Rahmati K, Lernmark A, Becker C, Foltyn-Zadura A, Larsson K, et al. (2008) A comparison of serum and EDTA plasma in the measurement of glutamic acid decarboxylase autoantibodies (GADA) and autoantibodies to islet antigen-2 (IA-2A) using the RSR radioimmunoassay (RIA) and enzyme linked immunosorbent assay (ELISA) kits. Clin Lab 54: 227-235.
13. Tuomilehto J, Yliharsila H, (1998) Antibodies as predictors of insulin-dependent diabetes mellitus before the clinical onset. Nutrition 14: 403-405.
14. Symmons DP, (2002) Epidemiology of rheumatoid arthritis: determinants of onset, persistence and outcome. Best Pract Res Clin Rheumatol 16: 707-722.
15. Simrén M, Abrahamsson H, Svedlund J, Björnsson ES, (2001) Quality of life in patients with irritable bowel syndrome seen in referral centers versus primary care: the impact of gender and predominant bowel pattern. Scand J Gastroenterol 36: 545-552.
16. Costagliola S, Morgenthaler NG, Hoermann R, Badenhoop K, Struck J, et al. (1999) Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease. J Clin Endocrinol Metab 84: 90-97.
17. Persson A, Becker C, Hansson I, Nilsson A, Törn C (2010) Comparison of Measurements of Autoantibodies to Glutamic Acid Decarboxylase and Islet Antigen-2 in Whole Blood Eluates from Dried Blood Spots Using the RSR-Enzyme Linked Immunosorbent Assay Kits and In-House Radioimmunoassays. Exp Diabetes Res. Online June 3.
18. Westman KWA, Selga D, Bygren P, Segelmark M, Baslund B, et al. (1998) Clinical evaluation of a capture ELISA for detection of proteinase-3 antineutrophil cytoplasmic antibody. Technical Note Kidney Int 53: 1230-1236.
19. Reichlin M (2006) Measurement and clinical significance of antinuclear antibodies. Up to date Online ver 15.1.
20. Mankaï A, Sakly W, Thabet Y, Achour A, Manoubi W, et al. (2013) Anti-Saccharomyces cerevisiae antibodies in patients with systemic lupus erythematosus. Rheumatol Int 33: 665-669.
21. www.analysporten-labmedicin.skane.se.
22. Svedlund J, Sjödin I, Dotevall G, (1988) GSRS - a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 33: 129-134.
23. Dimenäs E, Glise H, Hallerbäck B, Hernqvist H, Svedlund J, et al. (1993) Quality of life in patients with upper gastrointestinal symptoms An improved evaluation of treatment regimens? Scand J Gastroenterol 28: 681-687.
24. Dimenäs E, Glise H, Hallerbäck B, Hernqvist H, Svedlund J, et al. (1995) Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer. Scand J Gastroenterol 30: 1046-1052.
25. Dimenäs E, Carlsson G, Glise H, Israelsson B, Wiklund I, (1996) Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease. Scand J Gastroenterol 31Suppl 221: 8-13.
26. Drossman DA, Corrazziari E, Delvaux M, Spiller R, Talley NJ,et al. Rome III: The Functional Gastrointestinal Disorders. McLean, VA: Degnon Associates; 2006.
27. Weng J, Ekelund M, Lehto M, Li H, Ekberg G, et al. (2002) Screening for MODY mutations, GAD antibodies, and Type 1 diabetes-associated HLA genotypes in women with gestational diabetes mellitus. Diabetes Care 25: 68-71.
28. Prummel MF, Wiersinga WM, (2005) Thyroid peroxidase autoantibodies in euthyroid subjects. Best Pract Res Clin Endocrinol Metab 19: 1-15.
29. Matthiesen LS, Berg G, Ernerudh J, Skogh T, (1999) A prospective study on the occurrence of autoantibodies in low-risk pregnancies. Eur J Obstet Gynecol Reprod Biol 83: 21-26.
30. Karabulut G, Kitapcioglu G, Inal V, Kalfa M, Yargucu F, et al. (2011) Cigarette smoking in primary Sjögren's syndrome: positive association only with ANA positivity. Mod Rheumatol 21: 602-607.
31. Fernandez-Banares F, Eseve M, Espinos JC, Roinach M, Forne M, et al. (2007) Drug consumption and the risk of microscopic colitis. Am J Gastroneterol 102: 324-330.
32. Yen EF, Pokhrel B, Du H, New S, Bianchi L, et al. (2012) Current and past cigarette smoking significantly increase risk for microscopic colitis. Inflamm Bowel Dis 18: 1835-1841.
33. Bjørnbak C, Engel PJ, Nielsen PL, Munck LK, (2011) Microscopic colitis: clinical findings, topography and persistence of histopathological subgroups. Aliment Pharmacol Ther 34: 1225-1234.
34. Lee S, Ogilvie RT, Dupre M, Gao ZH, (2009) Intravascular lymphocytosis in acute appendicitis: potential mimicry of chronic lymphocytic leukaemia. Histopathology 55: 660-664.
35. Olesen M, Eriksson S, Bohr J, Järnerot G, Tysk C, (2004) Lymphocytic colitis: a retrospective clinical study of 199 Swedish patients. Gut 53: 536-541.
36. Miehlke S, Madisch A, Karimi D, Wonschik S, Kuhlisch E, et al. (2009) Budesonide is effective in treating lymphocytic colitis: a randomized double-blind placebo-controlled study. Gastroenterology 136: 2092-2100.
37. Bonderup OK, Hansen JB, Teglbjaerg PS, Christensen LA, Fallingborg JF, (2009) Long-term budesonide treatment of collagenous colitis: a randomised, double-blind, placebo-controlled trial. Gut 58: 68-72.
38. Rasmussen MA, Munck LK, (2012) Systematic review: are lymphocytic colitis and collagenous colitis two subtypes of the same disease-microscopic colitis? Aliment Pharmacol Ther 36: 79-90.
39. Stewart M, Andrews CN, Urbanski S, Beck PL, Storr M, (2011) The association of celiac disease and micrscopic colitis: a large population-based study. Aliment Pharmacol Ther 33: 1340-1349.
40. Dahlquist GG, Nyström L, (2011) Patterson CC; Swedish Childhood Diabetes Study Group (2011) Diabetes Incidence in Sweden Study Group. Incidence of type 1 diabetes in Sweden among individuals aged 0-34 years, 1983-2007: an analysis of time trends. Diabetes Care 34: 1754-1759.
41. Roth B, Ohlsson B, (2013) Gastrointestinal symptoms and psychological well-being in patients with microscopic colitis. Scand J Gastroenterol 48: 27-34.